Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
The effects of ketamine on typical and atypical depressive symptoms.
Journal: Acta psychiatrica Scandinavica
Published: July 10, 2020
RETRACTED: F173. Negative Trial of Scopolamine in Major Depressive Disorder Does Not Demonstrate Neurophysiological Changes Seen With the Antidepressant Response of Ketamine.
Journal: Biological psychiatry
Published: May 01, 2018
Clinical Trial of the Potassium Channel Activator Diazoxide for Major Depressive Disorder Halted Due to Intolerability.
Journal: Journal of clinical psychopharmacology
Published: March 31, 2018
Neurophysiological Changes Associated with Antidepressant Response to Ketamine Not Observed in a Negative Trial of Scopolamine in Major Depressive Disorder.
Journal: The international journal of neuropsychopharmacology
Published: March 03, 2018
The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder.
Journal: Journal of psychopharmacology (Oxford, England)
Published: October 18, 2017
Parsing the heterogeneity of depression: An exploratory factor analysis across commonly used depression rating scales.
Journal: Journal of affective disorders
Published: August 14, 2017
A Double-Blind, Placebo-Controlled, Pilot Study of Riluzole Monotherapy for Acute Bipolar Depression.
Journal: Journal of clinical psychopharmacology
Published: March 25, 2017
Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression.
Journal: Drugs
Published: February 15, 2017
Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorder.
Journal: Molecular psychiatry
Published: January 13, 2017
Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine.
Journal: Biological psychiatry
Published: February 23, 2016
Cortical abnormalities and association with symptom dimensions across the depressive spectrum.
Journal: Journal of affective disorders
Published: August 17, 2015
Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial.
Journal: Psychological medicine
Published: August 13, 2015
Last Updated: 09/26/2026